-
1Academic Journal
Authors: R. A. Osokin, I. A. Aboyan, E. F. Komarova, A. Yu. Maksimov, E. Yu. Komarova, Р. А. Осокин, И. А. Абоян, Е. Ф. Комарова, А. Ю. Максимов, Е. Ю. Комарова
Source: Cancer Urology; Том 16, № 1 (2020); 27-34 ; Онкоурология; Том 16, № 1 (2020); 27-34 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2020-16-1
Subject Terms: ангиотензинпревращающий фермент, arterial hypertension, local renin-angiotensin system, angiotensin, angiotensin converting enzyme, артериальная гипертензия, локальная ренин-ангиотензин-альдостероновая система, ангиотензин
File Description: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/998/1149; Stocks T., Van Hemelrijck M., Manjer J. et al. Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project. Hypertension 2012;59(4):802–10. DOI:10.1161/HYPERTENSIONAHA.111.189258.; Aune D., Sen A., Vatten L.J. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of casecontrol and cohort studies. Sci Rep 2017;7:44808. DOI:10.1038/srep44808.; Liang Z., Xie B., Li J. et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep 2016;6:31358. DOI:10.1038/srep31358.; Hidayat K., Du X., Zou S.Y., Shi B.M. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens 2017;35(7):1333–44. DOI:10.1097/HJH.0000000000001286.; Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 2006;20(5): 953–70. DOI:10.1210/me.2004-0536.; Lau S.T., Leung P.S. Role of the RAS in pancreatic cancer. Curr Cancer Drug Targets 2011;11(4):412–20.; Wegman-Ostrosky T., Soto-Reyes E., Vidal-Millán S. et al. The renin-angiotensin system meets the hallmarks of cancer. Renin Angiotensin Aldosterone Syst 2015;16(2):227–33. DOI:10.1177/1470320313496858.; Arrieta O., Villarreal-Garza C., Vizcaino G. et al. Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer. Tumour Biol 2015;36(7): 5627–34. DOI:10.1007/s13277-015-3235-3.; Osokin R., Kit O.I., Komarova E. et al. Urinary excretion of components of the renin-angiotensin-aldosterone system in patients having localized renal cancer. J Clin Oncol 2019;37:abstr_e14725.; Alvarenga E.C., Fonseca M.C., Carvalho C.C. et al. Angiotensin converting enzyme regulates cell proliferation and migration. PLoS One 2016;11(12):e0165371. DOI:10.1371/journal.pone.0165371.; Кит О.И., Абоян И.А., Осокин Р.А. и др. Артериальная гипертензия и рак почки: некоторые аспекты проблемы. Уральский медицинский журнал 2018;3(158):42–6. [Kit O.I., Aboyan I.A., Osokin R.A. et al. Arterial hypertension some aspects of problem. Ural’skiy medicinskiy zhurnal = Ural Medical Journal 2018;3(158):42–6. (In Russ)].; Sobczuk P., Szczylik C., Porta C. et al. Renin angiotensin system deregulation as renal cancer risk factor. Oncol Lett 2017; 14(5):5059–68. DOI:10.3892/ol.2017.6826.; Errarte P., Beitia M., Perez I. et al. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients. PLoS One 2017;12(8):e0181711. DOI:10.1371/journal.pone.0181711.; Larrinaga G., Pérez I., Sanz B. et al. Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors. Regul Pept 2010;165(2–3):218–23. DOI:10.1016/j.regpep.2010.07.17.; Gallagher P.E., Arter A.L., Deng G., Tallant E.A. Angiotensin-(1–7): a peptide hormone with anti-cancer activity. Curr Med Chem 2014;21(21):2417–23. DOI:10.2174/0929867321666140205133357.; Zheng S., Yang Y., Song R. et al. Ang-(1–7) promotes the migration and invasion of human renal cell carcinoma cells via Masmediated AKT signaling pathway. Biochem Biophys Res Commun 2015;460(2):333–40. DOI:10.1016/j.bbrc.2015.03.035.; Beyazit Y., Purnak T., Suvak B. et al. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clin Res Hepatol Gastroenterol 2011;35(10):644–9. DOI:10.1016/j.clinre.2011.06.008.; Herr D., Sauer C., Holzheu I. et al. Role of renin-angiotensin-system in human breast cancer cells: is there a difference in regulation of angiogenesis between hormone-receptor positive and negative breast cancer cells? Geburtshilfe Frauenheilkd 2019;79(6):626–34. DOI:10.1158/1535-7163.MCT-09-0161.; Bernardi S., Zennaro C., Palmisano S. et al. Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. J Renin Angiotensin Aldosterone Syst 2012;13(1):202–9. DOI:10.1177/1470320311426023.; Yu C., Tang W., Wang Y. et al. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry. Cancer Lett 2016;376(2):268–77. DOI:10.1016/j.canlet.2016.04.006.; Xu J., Jinshuo F., Feng W. et al. The ACE2/ Angiotensin-(1–7)/Mas receptor axis: pleiotropic roles in cancer. Front Physiol 2017; 8:276. DOI:10.3389/fphys.2017.00276.; Zimmerman D., Burns K.D. Angiotensin-(1–7) in kidney disease: a review of the controversies. Clin Sci (Lond) 2012;123(6): 333–46. DOI:10.1042/CS20120111.; https://oncourology.abvpress.ru/oncur/article/view/998